The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management
Usher, K., Foster, K., and Park, T. (2006) The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management. Journal of Psychiatric and Mental Health Nursing, 13 (6). pp. 730-734.
PDF (Published Version)
- Published Version
The introduction of second-generation antipsychotic drugs for the treatment of schizophrenia has provided significant benefits for clients experiencing this disorder. While they have been found effective in reducing psychotic symptoms, there is evidence that these drugs are also linked with a group of side effects commonly known as the metabolic syndrome. Mental health nurses are well positioned to prevent, detect and/or manage the development of this problematic constellation of symptoms. Guidelines for practice can be useful in prevention and management of the syndrome and enhance nursing care of clients who are taking second-generation antipsychotics.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||diabetes; metabolic syndrome; obesity; second-generation antipsychotic drugs; syndrome X|
|Date Deposited:||24 Nov 2009 01:30|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1110 Nursing > 111005 Mental Health Nursing @ 100%|
|SEO Codes:||92 HEALTH > 9202 Health and Support Services > 920210 Nursing @ 100%|
|Citation Count from Web of Science||
Last 12 Months: 32